Drug safety notice: Rosuvastatin tablets

September 14, 2021

We have been informed by manufacturers that an error with the patient information leaflets that have been packaged in some Rosuvastatin products where they do not include the most up to date safety information.

Due to supply and shortage considerations, the product is not currently subject to recall.

Please see Rosuvastatin information sheet for further details including batches which may be affected.

We ask that colleagues be mindful that patients may bring in affected batches from home and should be advised appropriately and have an updated patient information leaflet which can be found by clicking here.

For more information please contact the pharmacy department on ext. 5263/3783.